ATHE - Alterity Therapeutics reports cash position of A$16.7M for Q1 FY24
2023-10-30 12:51:12 ET
More on Alterity Therapeutics
- Alterity Therapeutics receives A$4.74M research & development tax incentive refund
- Seeking Alpha’s Quant Rating on Alterity Therapeutics
- Historical earnings data for Alterity Therapeutics
For further details see:
Alterity Therapeutics reports cash position of A$16.7M for Q1 FY24